Cancer Diagnostics

A Cancer Blood Test should be more than yes no maybe. 

Get More.

Get more from your cancer blood tests with VDI Cancer Diagnostics


  • Context-sensitive interpretation
  • Type-specific cancer panels
  • Insight to other concurrent diseases
  • Guidance when it’s NOT cancer
  • Patient support w/ Test & Treat solutions and supportive tests for the sick animal
  • Baseline for monitoring
  • VALUE from a single blood test

…BUT the value does stop at one test

  • The BEST tool for monitoring cancer therapy and disease progression
  • Minimal sample volume, low cost
  • Identify significant changes, trends, and detect disease recurrence
  • Adjust therapy protocol when ineffective

Monitoring That Makes Sense

VDI Blood Tests

Cancer Panel – General20130.5 mL serumInitial:
ADR or suspicious mass

• Disease progression
• Therapy efficacy
• Metastasis
• Recurrence
Cancer Panel – Lymphoma201b30.5 mL serumInitial:
Suspected LSA

• Disease progression
• Therapy efficacy
• Metastasis
• Recurrence
Pre-Stem Cell Therapy Panel20540.75 mL serumInitial:
Patient evaluation prior to stem cell therapy
Pericardial Effusion Panel20620.25 mL serum x2Initial:
Suspected heart cancer
GI Lymphoma Panel22850.5 mL serumInitial:

• Disease progression
• Therapy efficacy
• GI Vitamin status
Advanced GI Panel
(learn more)
260121 mL serumInitial:
IBD, LSA, Pancreatitis, PLE, SIBO, Malabsorption, Dietary Deficiencies

• Reflex to base cancer panel for Cancer/IBD monitoring.
• Reflex to GI Vitamins panel for nutritional monitoring

Cancer Panel

Blood tests for the detection and management of suspected cancer

Cancer Panel

The Cancer panel is dual-marker blood test for diagnosing and managing cancer in a variety of tumor types in dogs and cats. Commonly used as a first-step diagnosis prior to, or in place of biopsy, the cancer panel can give you confidence that neoplasia is present, and if proceeding to more invasive costly workup or referral to specialists is warranted. After diagnosis is made, the Cancer Panel can be used to monitor disease progression or therapy outcomes.

Common Applications:

  • Lymphoma
  • Abdominal mass
  • Solid tumors
  • Mast Cell Tumors (stage II)
  • ADR dog/cat
  • Hypercalcemia of malignancy
  • Chemotherapy management
  • Post mass-removal confirmation
  • Metastatic Disease

Not recommended for:

  • Cutaneous masses
  • Mast Cell Tumors (stage I)
  • Brain tumors

Reports Include:

  • TK1 result
  • C-Reactive Protein (dog) or Haptoglobin (HPT) result
  • Neoplasia Index (NI)
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Canine Reports:

Sample Feline Reports:

Pericardial Effusion Panel

The Canine Pericardial Effusion Panel uses TK1 from serum and pericardial fluid to determine if the source of the effusion is due to cancer. Neoplastic causes of PCE, particularly hemangiosarcoma, impart a significantly worse prognosis than non-neoplastic etiologies. Ratio of TK1 serum to pericardial fluid is able to rule-out cancer effectively. Contact VDI for more information on the Pericardial Effusion Panel.

GI Lymphoma Panel

Blood tests for the detection and management of suspected GI cancer

GI Lymphoma Panel

The GI Lymphoma Panel is a 4-marker panel used for the diagnosis of GI LSA in the acutely ill cat or dog. Cats are notorious for GI inflammatory disease, and it continues to be one of the harder determinations we see. As GI disease progresses if often times overlaps with the development of Lymphoma – making the differential determination challenging using ultrasound alone. Reluctance and inability to biopsy leaves diagnosis a guess. The GI LSA panel takes the guesswork out.


  • GI Lymphoma
  • Chronic progressive IBD
  • ADR cat or dog
  • Chemotherapy management

Reports Include:

  • TK1 result
  • HPT (cat) or CRP (dog) result
  • B12/ Folate results
  • B12 dosing guidelines
  • Neoplasia Index (NI) GILSA
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Reports:

Equine Lymphoma

Thymidine Kinase Type 1 – Equine Lymphoma Test

Thymidine Kinase Type 1 (TK1) is a DNA proliferation marker that has been shown in a number of human and animal studies to be highly elevated in Lymphoma. High cellular turnover, especially in aggressive & poorly differentiated lymphoma, gives lymphoma a robust TK1 response that is readily picked up in blood serum. Measurement of TK1 activity can be a rule-in for lymphoma in the suspected horse.